Our research is focused on elucidating the role of heterotypic cell-cell interactions in both normal physiological processes and disease pathogenesis. We aim to identify and characterize molecular markers associated with disease progression, with the ultimate goal of discovering novel therapeutic targets. To complement our experimental work, we are developing in vitro models of disease progression to validate our findings.
Our current focus is on investigating the involvement of developmental pathway genes in the progression of gastric and breast cancer. Additionally, we are exploring the impact of Wnt pathway modulation in lumbar stenosis. We foster strong collaborations with clinicians and computational biologists to advance our research.